MedPath

Medical University of South Carolina

Medical University of South Carolina logo
🇺🇸United States
Ownership
Private
Established
1955-01-01
Employees
10K
Market Cap
-
Website
https://www.muschealth.com

Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

First Posted Date
2016-11-03
Last Posted Date
2019-12-26
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
25
Registration Number
NCT02953873
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

Not Applicable
Completed
Conditions
Immunosuppression
Interventions
First Posted Date
2016-11-03
Last Posted Date
2019-12-24
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
40
Registration Number
NCT02954198
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control

Phase 2
Completed
Conditions
Alcohol Use Disorder
Interventions
Drug: Placebo
Drug: Tolcapone
First Posted Date
2016-10-31
Last Posted Date
2023-06-09
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
90
Registration Number
NCT02949934
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis

Phase 1
Completed
Conditions
Chronic Pancreatitis
Interventions
Drug: Placebo
Drug: Prolastin-C
First Posted Date
2016-10-27
Last Posted Date
2023-06-29
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
48
Registration Number
NCT02947087
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
Drug: Metformin
Other: OPC
First Posted Date
2016-10-27
Last Posted Date
2025-01-03
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
41
Registration Number
NCT02946996
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Oxytocin for Couples Conflict Resolution

Phase 2
Completed
Conditions
Substance Misuse
Interpersonal Conflict
Neuroendocrine Reactivity
Interventions
Drug: Oxytocin
Drug: Placebo
First Posted Date
2016-10-21
Last Posted Date
2018-10-12
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
66
Registration Number
NCT02941692

TMS for Adults With Autism and Depression

Not Applicable
Completed
Conditions
Depression
Depressive Disorder
Major Depressive Disorder
Autism Spectrum Disorder
Interventions
Device: NeuroStar® TMS device (Neuronetics, Atlanta, GA)
First Posted Date
2016-10-20
Last Posted Date
2019-10-01
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
13
Registration Number
NCT02939560
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

Phase 2
Withdrawn
Conditions
Carcinoma, Hepatocellular
Interventions
First Posted Date
2016-10-20
Last Posted Date
2019-09-12
Lead Sponsor
Medical University of South Carolina
Registration Number
NCT02939807
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues

Early Phase 1
Completed
Conditions
Alcohol Dependance
Interventions
Device: dorsolateral prefrontal cortex
Device: sham
Device: medial prefrontal cortex
First Posted Date
2016-10-20
Last Posted Date
2022-01-13
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
71
Registration Number
NCT02939313
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

Early Phase 1
Completed
Conditions
Alcoholism
Cocaine Addiction
Drug Addiction
Interventions
Device: Real continuous Theta Burst Stimulation
Device: Sham continuous Theta Burst Stimulation
First Posted Date
2016-10-20
Last Posted Date
2018-07-23
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
49
Registration Number
NCT02939352
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath